ARTICLES BY THIS AUTHOR
- 6/12/2012
Baby heart, there’s a new mobile app for that
A first-of-its-kind mobile application is giving neonatologists quick and reliable guidance when undertaking cardiac assessments on newborns. - 6/12/2012
St. John's Rehab and Sunnybrook approve merger agreement
TORONTO _ St. John’s Rehab Hospital and Sunnybrook Health Sciences Centre have agreed to merge voluntarily into a single, comprehensive healthcare provider. - 6/12/2012
Remote dispensing firm bankrupt
Just a year after the Ontario government gave the green light to remote dispensing machines, the fate of the controversial technology is up in the air with the bankruptcy of PharmaTrust. - 6/12/2012
International standards launched for clinical trials on children
Researchers have developed new clinical trial standards to help speed up research, improve patient treatment and focus international efforts on child health in Canada and around the world. - 6/12/2012
CLINICAL PEARLS: The value of continuity
- 6/12/2012
Male pattern baldness linked to prostate cancer
But finger-length ratio not a risk factor, Canadian study shows - 6/12/2012
B.C. company receives NRC funding for HIV/AIDS treatment
Vancouver-based iCo Therapeutics, a drug reprofiling company, has been awarded a $1.1 million non-repayable financial contribution from the National Research Council of Canada to support iCo’s Oral Amphotericin B (Amp B) delivery system as novel treatment for patients with Human Immunodeficiency Virus (HIV). - 6/12/2012
NEW DRUGS: Potassium channel blocker improves walking in MS
FAMPYRA (fampridine 10 mg sustained-release tablets), Biogen Idec. Also known as 4-aminopyridine or dalfampridine.